[1]
F. . Monteforte and J. . González-Argote, “Advances in the use of Ruxolitinib in the treatment of vitiligo disease”, Salud, Ciencia y Tecnología - Serie de Conferencias, vol. 2, p. 324, Sep. 2023, doi: 10.56294/sctconf2023324.